TY  - JOUR
AU  - Erton, Zeynep Belce
AU  - Sevim, Ecem
AU  - de Jesús, Guilherme Ramires
AU  - Cervera, Ricard
AU  - Ji, Lanlan
AU  - Pengo, Vittorio
AU  - Ugarte, Amaia
AU  - Andrade, Danieli
AU  - Andreoli, Laura
AU  - Atsumi, Tatsuya
AU  - Fortin, Paul R
AU  - Gerosa, Maria
AU  - Zuo, Yu
AU  - Petri, Michelle
AU  - Sciascia, Savino
AU  - Tektonidou, Maria G
AU  - Aguirre-Zamorano, Maria Angeles
AU  - Branch, D Ware
AU  - Erkan, Doruk
AU  - APS ACTION
PY  - 2022
DO  - 10.1136/lupus-2021-000633
SN  - 2053-8790
UR  - http://hdl.handle.net/10668/20164
T2  - Lupus science & medicine
AB  - To describe the outcomes of pregnancies in antiphospholipid antibody (aPL)-positive patients since the inception of the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking Registry. We identified persistently...
LA  - en
KW  - antibodies, anticardiolipin
KW  - antibodies, antiphospholipid
KW  - antiphospholipid syndrome
KW  - Abortion, Spontaneous
KW  - Antibodies, Antiphospholipid
KW  - Antiphospholipid Syndrome
KW  - Female
KW  - Fetal Death
KW  - Humans
KW  - Infant, Newborn
KW  - Lupus Erythematosus, Systemic
KW  - Placenta
KW  - Pre-Eclampsia
KW  - Pregnancy
KW  - Pregnancy Outcome
KW  - Prospective Studies
KW  - Registries
TI  - Pregnancy outcomes in antiphospholipid antibody positive patients: prospective results from the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository ('Registry').
TY  - research article
VL  - 9
ER  -